ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antithrombin (Recombinant) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19U8103
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and Japan Antithrombin Recombinant Market Insights Forecast to 2027
BUY CHAPTERS

Global Antithrombin (Recombinant) Market Research Report 2025

Code: QYRE-Auto-19U8103
Report
July 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
LFB Biotechnologies

Antithrombin (Recombinant) Market Size

The global market for Antithrombin (Recombinant) was valued at US$ 26.5 million in the year 2024 and is projected to reach a revised size of US$ 33 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Antithrombin (Recombinant) Market

Antithrombin (Recombinant) Market

Recombinant antithrombins with properties similar to those of normal human antithrombin have been produced using baculovirus-infected insect cells and mammalian cell lines grown in cell culture.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antithrombin (Recombinant), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antithrombin (Recombinant).
The Antithrombin (Recombinant) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antithrombin (Recombinant) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antithrombin (Recombinant) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antithrombin (Recombinant) Market Report

Report Metric Details
Report Name Antithrombin (Recombinant) Market
Accounted market size in year US$ 26.5 million
Forecasted market size in 2031 US$ 33 million
CAGR 3.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Lyophilized Formulation
  • Lyophilized Powder
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company LFB Biotechnologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antithrombin (Recombinant) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antithrombin (Recombinant) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Antithrombin (Recombinant) Market growing?

Ans: The Antithrombin (Recombinant) Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Antithrombin (Recombinant) Market size in 2031?

Ans: The Antithrombin (Recombinant) Market size in 2031 will be US$ 33 million.

Who are the main players in the Antithrombin (Recombinant) Market report?

Ans: The main players in the Antithrombin (Recombinant) Market are LFB Biotechnologies

What are the Application segmentation covered in the Antithrombin (Recombinant) Market report?

Ans: The Applications covered in the Antithrombin (Recombinant) Market report are Hospital, Clinic

What are the Type segmentation covered in the Antithrombin (Recombinant) Market report?

Ans: The Types covered in the Antithrombin (Recombinant) Market report are Lyophilized Formulation, Lyophilized Powder

Recommended Reports

Blood Disorder Therapies

Anticoagulant Markets

Recombinant & RNA Drugs

1 Antithrombin (Recombinant) Market Overview
1.1 Product Definition
1.2 Antithrombin (Recombinant) by Type
1.2.1 Global Antithrombin (Recombinant) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lyophilized Formulation
1.2.3 Lyophilized Powder
1.3 Antithrombin (Recombinant) by Application
1.3.1 Global Antithrombin (Recombinant) Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Antithrombin (Recombinant) Market Size Estimates and Forecasts
1.4.1 Global Antithrombin (Recombinant) Revenue 2020-2031
1.4.2 Global Antithrombin (Recombinant) Sales 2020-2031
1.4.3 Global Antithrombin (Recombinant) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antithrombin (Recombinant) Market Competition by Manufacturers
2.1 Global Antithrombin (Recombinant) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antithrombin (Recombinant) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antithrombin (Recombinant) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antithrombin (Recombinant), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antithrombin (Recombinant), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antithrombin (Recombinant), Product Type & Application
2.7 Global Key Manufacturers of Antithrombin (Recombinant), Date of Enter into This Industry
2.8 Global Antithrombin (Recombinant) Market Competitive Situation and Trends
2.8.1 Global Antithrombin (Recombinant) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antithrombin (Recombinant) Players Market Share by Revenue
2.8.3 Global Antithrombin (Recombinant) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antithrombin (Recombinant) Market Scenario by Region
3.1 Global Antithrombin (Recombinant) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antithrombin (Recombinant) Sales by Region: 2020-2031
3.2.1 Global Antithrombin (Recombinant) Sales by Region: 2020-2025
3.2.2 Global Antithrombin (Recombinant) Sales by Region: 2026-2031
3.3 Global Antithrombin (Recombinant) Revenue by Region: 2020-2031
3.3.1 Global Antithrombin (Recombinant) Revenue by Region: 2020-2025
3.3.2 Global Antithrombin (Recombinant) Revenue by Region: 2026-2031
3.4 North America Antithrombin (Recombinant) Market Facts & Figures by Country
3.4.1 North America Antithrombin (Recombinant) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antithrombin (Recombinant) Sales by Country (2020-2031)
3.4.3 North America Antithrombin (Recombinant) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antithrombin (Recombinant) Market Facts & Figures by Country
3.5.1 Europe Antithrombin (Recombinant) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antithrombin (Recombinant) Sales by Country (2020-2031)
3.5.3 Europe Antithrombin (Recombinant) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antithrombin (Recombinant) Market Facts & Figures by Region
3.6.1 Asia Pacific Antithrombin (Recombinant) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antithrombin (Recombinant) Sales by Region (2020-2031)
3.6.3 Asia Pacific Antithrombin (Recombinant) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antithrombin (Recombinant) Market Facts & Figures by Country
3.7.1 Latin America Antithrombin (Recombinant) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antithrombin (Recombinant) Sales by Country (2020-2031)
3.7.3 Latin America Antithrombin (Recombinant) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antithrombin (Recombinant) Market Facts & Figures by Country
3.8.1 Middle East and Africa Antithrombin (Recombinant) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antithrombin (Recombinant) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antithrombin (Recombinant) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antithrombin (Recombinant) Sales by Type (2020-2031)
4.1.1 Global Antithrombin (Recombinant) Sales by Type (2020-2025)
4.1.2 Global Antithrombin (Recombinant) Sales by Type (2026-2031)
4.1.3 Global Antithrombin (Recombinant) Sales Market Share by Type (2020-2031)
4.2 Global Antithrombin (Recombinant) Revenue by Type (2020-2031)
4.2.1 Global Antithrombin (Recombinant) Revenue by Type (2020-2025)
4.2.2 Global Antithrombin (Recombinant) Revenue by Type (2026-2031)
4.2.3 Global Antithrombin (Recombinant) Revenue Market Share by Type (2020-2031)
4.3 Global Antithrombin (Recombinant) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antithrombin (Recombinant) Sales by Application (2020-2031)
5.1.1 Global Antithrombin (Recombinant) Sales by Application (2020-2025)
5.1.2 Global Antithrombin (Recombinant) Sales by Application (2026-2031)
5.1.3 Global Antithrombin (Recombinant) Sales Market Share by Application (2020-2031)
5.2 Global Antithrombin (Recombinant) Revenue by Application (2020-2031)
5.2.1 Global Antithrombin (Recombinant) Revenue by Application (2020-2025)
5.2.2 Global Antithrombin (Recombinant) Revenue by Application (2026-2031)
5.2.3 Global Antithrombin (Recombinant) Revenue Market Share by Application (2020-2031)
5.3 Global Antithrombin (Recombinant) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 LFB Biotechnologies
6.1.1 LFB Biotechnologies Company Information
6.1.2 LFB Biotechnologies Description and Business Overview
6.1.3 LFB Biotechnologies Antithrombin (Recombinant) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 LFB Biotechnologies Antithrombin (Recombinant) Product Portfolio
6.1.5 LFB Biotechnologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antithrombin (Recombinant) Industry Chain Analysis
7.2 Antithrombin (Recombinant) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antithrombin (Recombinant) Production Mode & Process Analysis
7.4 Antithrombin (Recombinant) Sales and Marketing
7.4.1 Antithrombin (Recombinant) Sales Channels
7.4.2 Antithrombin (Recombinant) Distributors
7.5 Antithrombin (Recombinant) Customer Analysis
8 Antithrombin (Recombinant) Market Dynamics
8.1 Antithrombin (Recombinant) Industry Trends
8.2 Antithrombin (Recombinant) Market Drivers
8.3 Antithrombin (Recombinant) Market Challenges
8.4 Antithrombin (Recombinant) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
LFB Biotechnologies
List of Tables
 Table 1. Global Antithrombin (Recombinant) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antithrombin (Recombinant) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antithrombin (Recombinant) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antithrombin (Recombinant) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Antithrombin (Recombinant) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antithrombin (Recombinant) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antithrombin (Recombinant) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antithrombin (Recombinant) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antithrombin (Recombinant), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antithrombin (Recombinant), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antithrombin (Recombinant), Product Type & Application
 Table 12. Global Key Manufacturers of Antithrombin (Recombinant), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antithrombin (Recombinant) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombin (Recombinant) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antithrombin (Recombinant) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antithrombin (Recombinant) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Antithrombin (Recombinant) Sales Market Share by Region (2020-2025)
 Table 19. Global Antithrombin (Recombinant) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Antithrombin (Recombinant) Sales Market Share by Region (2026-2031)
 Table 21. Global Antithrombin (Recombinant) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antithrombin (Recombinant) Revenue Market Share by Region (2020-2025)
 Table 23. Global Antithrombin (Recombinant) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antithrombin (Recombinant) Revenue Market Share by Region (2026-2031)
 Table 25. North America Antithrombin (Recombinant) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antithrombin (Recombinant) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Antithrombin (Recombinant) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Antithrombin (Recombinant) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antithrombin (Recombinant) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antithrombin (Recombinant) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antithrombin (Recombinant) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Antithrombin (Recombinant) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Antithrombin (Recombinant) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antithrombin (Recombinant) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antithrombin (Recombinant) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antithrombin (Recombinant) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Antithrombin (Recombinant) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Antithrombin (Recombinant) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antithrombin (Recombinant) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antithrombin (Recombinant) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antithrombin (Recombinant) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Antithrombin (Recombinant) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Antithrombin (Recombinant) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antithrombin (Recombinant) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antithrombin (Recombinant) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antithrombin (Recombinant) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Antithrombin (Recombinant) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Antithrombin (Recombinant) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antithrombin (Recombinant) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antithrombin (Recombinant) Sales (K Units) by Type (2020-2025)
 Table 51. Global Antithrombin (Recombinant) Sales (K Units) by Type (2026-2031)
 Table 52. Global Antithrombin (Recombinant) Sales Market Share by Type (2020-2025)
 Table 53. Global Antithrombin (Recombinant) Sales Market Share by Type (2026-2031)
 Table 54. Global Antithrombin (Recombinant) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antithrombin (Recombinant) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antithrombin (Recombinant) Revenue Market Share by Type (2020-2025)
 Table 57. Global Antithrombin (Recombinant) Revenue Market Share by Type (2026-2031)
 Table 58. Global Antithrombin (Recombinant) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Antithrombin (Recombinant) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Antithrombin (Recombinant) Sales (K Units) by Application (2020-2025)
 Table 61. Global Antithrombin (Recombinant) Sales (K Units) by Application (2026-2031)
 Table 62. Global Antithrombin (Recombinant) Sales Market Share by Application (2020-2025)
 Table 63. Global Antithrombin (Recombinant) Sales Market Share by Application (2026-2031)
 Table 64. Global Antithrombin (Recombinant) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antithrombin (Recombinant) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antithrombin (Recombinant) Revenue Market Share by Application (2020-2025)
 Table 67. Global Antithrombin (Recombinant) Revenue Market Share by Application (2026-2031)
 Table 68. Global Antithrombin (Recombinant) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Antithrombin (Recombinant) Price (US$/Unit) by Application (2026-2031)
 Table 70. LFB Biotechnologies Company Information
 Table 71. LFB Biotechnologies Description and Business Overview
 Table 72. LFB Biotechnologies Antithrombin (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. LFB Biotechnologies Antithrombin (Recombinant) Product
 Table 74. LFB Biotechnologies Recent Developments/Updates
 Table 75. Key Raw Materials Lists
 Table 76. Raw Materials Key Suppliers Lists
 Table 77. Antithrombin (Recombinant) Distributors List
 Table 78. Antithrombin (Recombinant) Customers List
 Table 79. Antithrombin (Recombinant) Market Trends
 Table 80. Antithrombin (Recombinant) Market Drivers
 Table 81. Antithrombin (Recombinant) Market Challenges
 Table 82. Antithrombin (Recombinant) Market Restraints
 Table 83. Research Programs/Design for This Report
 Table 84. Key Data Information from Secondary Sources
 Table 85. Key Data Information from Primary Sources
 Table 86. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antithrombin (Recombinant)
 Figure 2. Global Antithrombin (Recombinant) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antithrombin (Recombinant) Market Share by Type: 2024 & 2031
 Figure 4. Lyophilized Formulation Product Picture
 Figure 5. Lyophilized Powder Product Picture
 Figure 6. Global Antithrombin (Recombinant) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Antithrombin (Recombinant) Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Antithrombin (Recombinant) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Antithrombin (Recombinant) Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Antithrombin (Recombinant) Sales (2020-2031) & (K Units)
 Figure 13. Global Antithrombin (Recombinant) Average Price (US$/Unit) & (2020-2031)
 Figure 14. Antithrombin (Recombinant) Report Years Considered
 Figure 15. Antithrombin (Recombinant) Sales Share by Manufacturers in 2024
 Figure 16. Global Antithrombin (Recombinant) Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Antithrombin (Recombinant) Players: Market Share by Revenue in Antithrombin (Recombinant) in 2024
 Figure 18. Antithrombin (Recombinant) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Antithrombin (Recombinant) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Antithrombin (Recombinant) Sales Market Share by Country (2020-2031)
 Figure 21. North America Antithrombin (Recombinant) Revenue Market Share by Country (2020-2031)
 Figure 22. United States Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Antithrombin (Recombinant) Sales Market Share by Country (2020-2031)
 Figure 25. Europe Antithrombin (Recombinant) Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Antithrombin (Recombinant) Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Antithrombin (Recombinant) Revenue Market Share by Region (2020-2031)
 Figure 33. China Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Antithrombin (Recombinant) Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Antithrombin (Recombinant) Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Antithrombin (Recombinant) Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Antithrombin (Recombinant) Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Antithrombin (Recombinant) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Antithrombin (Recombinant) by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Antithrombin (Recombinant) by Type (2020-2031)
 Figure 54. Global Antithrombin (Recombinant) Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Antithrombin (Recombinant) by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Antithrombin (Recombinant) by Application (2020-2031)
 Figure 57. Global Antithrombin (Recombinant) Price (US$/Unit) by Application (2020-2031)
 Figure 58. Antithrombin (Recombinant) Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Recombinant Human Thrombin Protein Market Research Report 2024
Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antithrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Hirudin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2024
Global Anti thrombin III Testing Market Insights Forecast to 2030
Global Topical Recombinant Human Thrombin Market Research Report 2024
Global Topical Recombinant Thrombin Market Research Report 2024
Global Human Thrombin Market Research Report 2024
Humanes Antithrombin III Konzentrat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Finished Dosage Form Antithrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Antithrombin III Market Research Report 2024
Recombinant Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Management of Antithrombin Market Research Report 2024
Global Thrombin Inhibitor Market Research Report 2024
Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Antibody Market Research Report 2025
Global Recombinant Plasma Proteins Market Insights Forecast to 2030
Global Recombinant Trypsin Market Insights Forecast to 2030
Global Non recombinant Coagulation Factors Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions